CS
NUVL

Candriam SCA’s Nuvalent NUVL Stock Holding History

Candriam SCA’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.1M Buy
391,306
+33,293
+9% +$3.39M 0.21% 105
2025
Q4 		$36M Buy
358,013
+28,292
+9% +$2.79M 0.18% 125
2025
Q3 		$28.5M Buy
329,721
+28,462
+9% +$2.25M 0.15% 138
2025
Q2 		$23M Sell
301,259
-52,870
-15% -$3.87M 0.13% 148
2025
Q1 		$25.1M Sell
354,129
-13,966
-4% -$1.09M 0.16% 136
2024
Q4 		$28.8M Buy
368,095
+49,728
+16% +$4.64M 0.17% 123
2024
Q3 		$32.6M Buy
318,367
+56,359
+22% +$4.67M 0.19% 118
2024
Q2 		$19.9M Sell
262,008
-22,001
-8% -$1.56M 0.12% 170
2024
Q1 		$21.3M Buy
284,009
+4,000
+1% +$318K 0.14% 158
2023
Q4 		$20.6M Sell
280,009
-70,008
-20% -$4.33M 0.14% 157
2023
Q3 		$16.1M Buy
350,017
+70,001
+25% +$3.11M 0.11% 171
2023
Q2 		$11.8M Sell
280,016
-43,835
-14% -$1.66M 0.09% 224
2023
Q1 		$7.78M Buy
323,851
+65,202
+25% +$1.93M 0.05% 294
2022
Q4 		$7.7M Buy
+258,649
New +$7.21M 0.05% 316

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Candriam SCA's NUVL Position: Q1 2026 in Review

Candriam SCA increased its Nuvalent (NUVL) stake by 9.3% in Q1 2026, buying an estimated $3.39M and bringing the position to 391,306 shares worth $40.1M. The position accounts for 0.21% of the portfolio, ranked #105.

Candriam SCA first reported a position in NUVL in Q4 2022 and has held it in 14 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Candriam SCA held 391,306 shares of Nuvalent worth $40.1M as of Q1 2026.
  • Candriam SCA bought 33,293 Nuvalent shares in Q1 2026, an estimated $3.39M.
  • Nuvalent made up 0.21% of Candriam SCA's portfolio in Q1 2026, its #105 holding.
  • Candriam SCA first reported a position in Nuvalent in Q4 2022 and has held it in 14 quarters since.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.